HPV Vaccination Cost Effectiveness Estimates
GHDx Entry last modified on: Apr 11, 2023
HPV
Dataset Records for HPV
Displaying 1 - 50 of 178
HPV Vaccination Cost Effectiveness Estimates
Tonga Multiple Indicator Cluster Survey 2019
Tonga MICS 2019
Survey:
Household - Individual - Interview - Urban-rural representative
Mexico National Survey of Health and Nutrition (ENSANUT) 2018-2019
Encuesta Nacional de Salud y Nutrición (ENSANUT) 2018
Survey:
Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
United States Behavioral Risk Factor Surveillance System 2018
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative
United States National Health and Nutrition Examination Survey 2017-2018
NHANES 2017-2018
Survey:
Cross-sectional - Exam - Household - Individual - Interview
Mexico SUIVE Epidemiology Bulletin Week 52, 2016
Boletín Epidemiológico Nacional Sistema de Vigilancia Epidemiológica Sistema Único de Información Semana 52, 2016
Epi surveillance:
Subnationally representative
United States Behavioral Risk Factor Surveillance System 2016
Survey:
Cross-sectional - Household - Individual - Interview - Subnationally representative
United States National Survey of Family Growth 2015-2017
2015-2017 NSFG
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
United States National Health and Nutrition Examination Survey 2015-2016
Survey:
Cross-sectional - Exam - Household - Individual - Interview - Nationally representative
Mexico SUIVE Epidemiology Bulletin Week 52, 2015
Boletín Epidemiológico Nacional Sistema de Vigilancia Epidemiológica Sistema Único de Información Semana 52, 2015
Epi surveillance:
Subnationally representative
Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland
GHDx Entry last modified on: Apr 10, 2023
Norway Surveillance System for Communicable Diseases 2015
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
Mexico Morbidity Yearbook 2014
Anuario de Morbilidad 2014
Epi surveillance:
Subnationally representative
Mexico SUIVE Epidemiology Bulletin Week 53, 2014
Boletín Epidemiológico Nacional Sistema de Vigilancia Epidemiológica Sistema Único de Información Semana 53, 2014
Epi surveillance:
Subnationally representative
Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage
GHDx Entry last modified on: Jan 31, 2023
Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
GHDx Entry last modified on: May 30, 2020
Norway Surveillance System for Communicable Diseases 2014
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
Oman Annual Health Report 2014
Report:
Subnationally representative
Mexico SUIVE Epidemiology Bulletin Week 52 2013
Boletín Epidemiológico Nacional Sistema de Vigilancia Epidemiológica Sistema Único de Información Semana 52, 2013
Epi surveillance:
Subnationally representative
Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR
GHDx Entry last modified on: May 30, 2020
The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach
GHDx Entry last modified on: Jan 31, 2023
United States National Health and Nutrition Examination Survey 2013-2014
Survey:
Cross-sectional - Exam - Household - Individual - Interview - Nationally representative
Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
GHDx Entry last modified on: May 30, 2020
Norway Surveillance System for Communicable Diseases 2013
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
Mexico Morbidity Yearbook 2013
Anuario de Morbilidad 2013
Epi surveillance:
Subnationally representative
United States National Survey of Family Growth 2013-2015
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
Oman Annual Health Report 2012
Report:
Subnationally representative
Canada Health Measures Survey 2012-2013
Canadian Health Measures Survey Cycle 3
Survey:
Cross-sectional - Exam - Household - Interview - Nationally representative
Sri Lanka Annual Health Bulletin 2012
GHDx Entry last modified on: Sep 15, 2021
Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras
GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil
GHDx Entry last modified on: Jan 31, 2023
Norway Surveillance System for Communicable Diseases 2012
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
Mexico Morbidity Yearbook 2012
Anuario de Morbilidad 2012
Epi surveillance:
Subnationally representative
Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study
GHDx Entry last modified on: May 30, 2020
United States National Survey of Family Growth 2011-2013
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
United States National Health Interview Survey 2011
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
GHDx Entry last modified on: Jan 31, 2023
United States National Health and Nutrition Examination Survey 2011-2012
Survey:
Cross-sectional - Exam - Household - Individual - Interview - Nationally representative
Norway Surveillance System for Communicable Diseases 2011
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis
GHDx Entry last modified on: Jan 31, 2023
Oman Annual Health Report 2011
GHDx Entry last modified on: Mar 22, 2023
Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia
GHDx Entry last modified on: May 30, 2020
United States National Health Interview Survey 2010
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA)
GHDx Entry last modified on: Jan 31, 2023
The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands
GHDx Entry last modified on: Jan 31, 2023
Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa
GHDx Entry last modified on: Jan 31, 2023
Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study
GHDx Entry last modified on: Jan 31, 2023
New Zealand Sexually Transmitted Infections Annual Surveillance Report 2014
GHDx Entry last modified on: Nov 6, 2018
Dominican Republic Health Statistical Yearbook 2010
Anuario de Estadísticas de Salud, 2010
Report:
Health facility - Subnationally representative
The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
GHDx Entry last modified on: Jan 31, 2023
Subscribe